Showing results (801-810 of 881) with videos related to
Sort By:
Pageof 89
Lancet Regional Health. Americas|May 21, 2026
Rapid hepatitis C test and treat with peer support at opioid treatment programs (RAPID HCV): a hybrid effectiveness-implementation type 1 randomized control trialOluwaseun Falade-Nwulia, Jennifer C Price, Jordan J Feld, et al.Gastroenterology|October 27, 2015
Effectiveness of Simeprevir Plus Sofosbuvir, With or Without Ribavirin, in Real-World Patients With HCV Genotype 1 InfectionMark S Sulkowski, Hugo E Vargas, Adrian M Di Bisceglie, et al.Gastroenterology|August 21, 2010
Hepatitis C virus treatment-related anemia is associated with higher sustained virologic response rateMark S Sulkowski, Mitchell L Shiffman, Nezam H Afdhal, et al.Journal of Viral Hepatitis|October 31, 2013
The new paradigm of hepatitis C therapy: integration of oral therapies into best practicesN H Afdhal, S Zeuzem, R T Schooley, et al.Journal of Hepatology|June 30, 2026
A precision randomized trial of hepatitis C treatment support among people who inject drugs in India: The STOP-C TrialSunil S Solomon, Aylur K Srikrishnan, Allison M McFall, et al.Hepatology (Baltimore, Md.)|November 4, 2025
AASLD/IDSA Practice Guideline on treatment of chronic hepatitis BMarc G Ghany, Calvin Q Pan, Anna S Lok, et al.American Journal of Transplantation : Official Journal of the American Society of Transplantation and the American Society of Transplant Surgeons|December 5, 2020
Retrospective-prospective study of safety and efficacy of sofosbuvir-based direct-acting antivirals in HIV/HCV-coinfected participants with decompensated liver disease pre- or post-liver transplantMarion G Peters, Shyam Kottilil, Norah Terrault, et al.The Lancet. HIV|October 2, 2015
Efficacy and safety of grazoprevir (MK-5172) and elbasvir (MK-8742) in patients with hepatitis C virus and HIV co-infection (C-EDGE CO-INFECTION): a non-randomised, open-label trialJürgen K Rockstroh, Mark Nelson, Christine Katlama, et al.Journal of Hepatology|January 22, 2017
NS5A resistance-associated substitutions in patients with genotype 1 hepatitis C virus: Prevalence and effect on treatment outcomeStefan Zeuzem, Masashi Mizokami, Stephen Pianko, et al.Journal of Viral Hepatitis|July 17, 2020
Sharing the cure: Building primary care and public health infrastructure to improve the hepatitis C care continuum in MarylandRisha Irvin, Boatemaa Ntiri-Reid, Mary Kleinman, et al.Pageof 89